3.7. Maternal Hematological and Iron Status Markers
We analyzed participants who completed the study with ≥80% adherence to examine changes in maternal hematological and iron status parameters by randomization group (Regarding the development of IDA, no participants in either treatment group displayed a Hb level indicative of IDA at 24–28 WG. However, at 34–36 WG, one participant in the 